Research Reports

Healthcare

icon
icon
Home » Reports » Meningitis Vaccine Market Global Demand Growth Analysis Opportunity Outlook 2023
Market Research Report

Meningitis Vaccine Market : Global Demand, Growth Analysis & Opportunity Outlook 2023

Published On : December, 2018 REP-ID-231 Category: Healthcare

Global Market Overview

Meningitis is a bacterial infection which occurs due to seasonal variations which born several harmful bacteria. Rising awareness towards vaccinations and rising incidents of meningitis across the globe are the main demand growing factors for the meningitis vaccine. Increase in healthcare expenditure across the globe by developing and emerging nations are changing the scenario of healthcare sector in order to provide better and effective cure. Emerging economies are adopting advanced vaccinations to minimize the burden of diseases which is further cutting down the figure of health expenditure. 

                        Meningitis Vaccine market

Market size and forecast

The global meningitis vaccine market was valued USD 2.1 Billion in 2015 and the market is further anticipated to garner USD 5.2 Billion by 2023. Further, the global meningitis vaccine market is predicted to flourish significantly at a CAGR of 14.5% over the forecast period i.e. 2016-2023.

North America accounted the highest market share in terms of revenue in overall market of meningitis vaccine across the globe. The market is expected to maintain its dominance over the forecast period on the back of rising government interventions, increasing healthcare expenditure, rising awareness towards meningitis by various immunization programs.

On the other hand, Asia-Pacific is expected to be the most opportunistic and fastest growing region across the globe in meningitis vaccines market due to growing demand for advanced vaccines in emerging nations such as India, China, etc. increase in GDP figure, and rising awareness towards healthcare in order to minimize the burden of diseases.

Further, boost in research and development in healthcare sector in order to develop low cost and effective vaccines for the consumers are likely to grow awareness towards vaccinations among the population. The market of meningitis vaccines is majorly driven by the factors such as introduction of low cost meningitis vaccines as those are more effective than the conventional vaccines.

Rising awareness towards meningitis diseases and their preventions and introduction of favorable re-imbursement policies by the government organizations across the globe are likely to shift the consumer to adopt advanced meningitis vaccines in order to minimize the disease burden.

The meningitis vaccine market is estimated to expand in terms of demand in near future on account of growing awareness towards cost-effective vaccines, and positive growth in GDP figure in developing nations.

Market Segmentation

Our in-depth analysis segmented the global meningitis vaccine market in the following segments:

By Diseases Type

  • Viral Meningitis
  • Bacterial Meningitis
  • Meningococcal Disease
  • Pneumococcal Meningitis
  • TB Meningitis
  • Fungal Meningitis
  • Hib Meningitis
  • Other types of Meningitis

By Product

  • Meningitis A+C
  • Meningitis ACWY135
  • Meningitis B

By Vaccines

  • Polysaccharide Vaccines
  • Conjugate Vaccines
  • Combination Vaccines

By End-User

  • Hospitals
  • Clinics/ Nursing homes
  • Research laboratories

By Region

Global Meningitis Vaccine Market is further classified on the basis of region as follows:

  • North America (United States /U.S. & Canada)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Western and Eastern Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Western Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia)
  • Middle East and North Africa (MENA)
  • Rest of World

Growth Drivers and challenges

Increase in child births coupled with high risk of bacterial infections due to low immunity of infants, rising incidents of meningitis due to lack of awareness towards hygiene, growing awareness towards advanced healthcare vaccinations are some of the factors driving the market of meningitis vaccine across the globe. Apart from this, factors such as introduction of cost-effective vaccinations, growing awareness towards early prevention and vaccinations, rising preferences by physicians towards vaccinations are some of the key elements prompting the demand for meningitis vaccines over the forecast period i.e. 2016-2023. Additionally, increase in personal disposable income of the population in developing regions and increasing healthcare spending owing to growing concern towards cure and treatment of various bacterial infections, rising concern towards early prevention and health-hygiene are some of the major key elements swelling the demand for meningitis vaccines.

However, high cost of meningitis vaccines, lack of awareness towards meningitis in under-developed nations, and lack of skilled healthcare physicians are some of the factors likely to restraint the market of meningitis vaccine across the globe.

Key Players

The key players of meningitis vaccine market are as follows:

  • GlaxoSmithKline
    • Company Overview
    • Key Product Offerings
    • Business Strategy
    • SWOT Analysis
    • Financials
  • Baxter International
  • Sanofi Pasteur
  • Merck
  • Pfizer
  • Zhejiang Tianyuan
  • Beijing Tiantan Biological

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The Global Meningitis Vaccine Market is segmented as follows:

  • By Diseases type Market Size and Y-O-Y Growth Analysis
  • By Product type Market Size and Y-O-Y Growth Analysis
  • By Vaccines type Market Size and Y-O-Y Growth Analysis
  • By End-user Market Size and Y-O-Y Growth Analysis

By Regions

  • North America (U.S., Canada) Market Size and Y-O-Y Growth Analysis
  • Latin America (Mexico, Brazil, Rest of Latin America) Market Size and Y-O-Y Growth Analysis
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe) Market Size and Y-O-Y Growth Analysis
  • Asia-Pacific (China, India, Singapore, Japan, Australia and New Zealand and Rest of Asia) Market Size and Y-O-Y Growth Analysis
  • Middle East and North Africa (MENA) Market Size and Y-O-Y Growth Analysis
  • Rest of World  Market Size and Y-O-Y Growth Analysis

Market Dynamics

Supply and Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

 

                Key Answers Captured in Report?

Which geography would have better demand for product/services?
What are the strategies adopted by big players in the regional market?
Which country would see the steep rise in CAGR & year-on-year (Y-O-Y) growth?
What is the current & expected market size in next five years?
What is the market feasibility for long term investment?
What opportunity the country would offer for existing and new players in the market?
What is risk involved for suppliers in the geography?
What factors would drive the demand for the product/service in near future?
What is the impact analysis of various factors in the market growth?
What are the recent trends in the regional market and how successful they are?

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

RELATED REPORTS

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com


UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Subscribe To Our Newsletters

Copyright © 2018 Research Nester. All rights reserved

Top